QHRD-110

N/A

Report date: 2026/01/08 20:00:10
NME

Base Information

Drug NameQHRD-110
Drug Alias NameQHRD-110
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 6 inhibitors
TargetsCyclin-dependent kinase 4Cyclin-dependent kinase 6
Therapy Area/IndicationsSolid tumoursCentral Nervous System NeoplasmsGlioblastoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChangzhou Qianhong Biopharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChangzhou Qianhong Biopharma Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCentral Nervous System NeoplasmsGlioblastoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A